Search research articles
Contact Us
Filters
Showing results (371-380 of 407) with videos related to
Page
of 41
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 26, 2010
A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma
Anne W M Lee, Stewart Y Tung, Anthony T C Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2004
Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA
Anthony T C Chan, Brigette B Y Ma, Y M Dennis Lo, et al.
Journal of the National Cancer Institute
|
January 3, 2024
Early detection of nasopharyngeal carcinoma: performance of a short contrast-free screening magnetic resonance imaging
Ann D King, Qi Yong H Ai, W K Jacky Lam, et al.
Oncogene
|
November 9, 2010
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death
V W Y Lui, E Y L Wong, K Ho, et al.
Clinical and Translational Radiation Oncology
|
December 22, 2021
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients
Pierre Blanchard, Anne W M Lee, Alexandra Carmel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2021
Dynamic Changes of Post-Radiotherapy Plasma Epstein-Barr Virus DNA in a Randomized Trial of Adjuvant Chemotherapy Versus Observation in Nasopharyngeal Cancer
Edwin Pun Hui, Brigette B Y Ma, W K Jacky Lam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial
A T C Chan, P M L Teo, R K Ngan, et al.
Cancer
|
February 26, 2013
Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program
K C Allen Chan, Emily C W Hung, John K S Woo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2019
Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma
A D King, J K S Woo, Q Y Ai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2022
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma
D C T Chan, W K J Lam, E P Hui, et al.
Page
of 41
Search research articles
Search
Showing results (371-380 of 407) with videos related to
Sort By:
Page
of 41
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 26, 2010
A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma
Anne W M Lee, Stewart Y Tung, Anthony T C Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2004
Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA
Anthony T C Chan, Brigette B Y Ma, Y M Dennis Lo, et al.
Journal of the National Cancer Institute
|
January 3, 2024
Early detection of nasopharyngeal carcinoma: performance of a short contrast-free screening magnetic resonance imaging
Ann D King, Qi Yong H Ai, W K Jacky Lam, et al.
Oncogene
|
November 9, 2010
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death
V W Y Lui, E Y L Wong, K Ho, et al.
Clinical and Translational Radiation Oncology
|
December 22, 2021
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients
Pierre Blanchard, Anne W M Lee, Alexandra Carmel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2021
Dynamic Changes of Post-Radiotherapy Plasma Epstein-Barr Virus DNA in a Randomized Trial of Adjuvant Chemotherapy Versus Observation in Nasopharyngeal Cancer
Edwin Pun Hui, Brigette B Y Ma, W K Jacky Lam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial
A T C Chan, P M L Teo, R K Ngan, et al.
Cancer
|
February 26, 2013
Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program
K C Allen Chan, Emily C W Hung, John K S Woo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2019
Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma
A D King, J K S Woo, Q Y Ai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2022
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma
D C T Chan, W K J Lam, E P Hui, et al.
Page
of 41